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Comparison of renal function after endovascular
aneurysm repair with different transrenally fixated
endografts
Thomas L. Forbes, MD, Gregory E. J. Harding, MD, D. Kirk Lawlor, MD, Guy DeRose, MD,
and Kenneth A. Harris, MD, London, ON, Canada
Objective: Transrenal fixation of abdominal aortic endografts may provide a more secure proximal attachment with few
deleterious effects with respect to renal function. This study’s purpose was to determine whether different metals used in
two commercially available endografts (Cook Zenith and Medtronic Talent) result in different effects on renal function
when placed across renal ostia.
Methods:A total of 140 consecutive patients, between August 2003 and April 2005, who underwent elective endovascular
repair of an aortic aneurysm with a nitinol or stainless steel–based endograft with transrenal fixation were reviewed with
a mean follow-up period of 5.5 months (range, 1-22 months). The main outcome variable was the percentage change in
creatinine clearance (CrCl), which was determined before surgery and at the most recent follow-up. Multiple regression
analysis was performed to analyze the contribution of various factors to any deterioration in renal function.
Results: The 140 patients were predominantly male (86%), with a mean age of 75 years (range, 56-92) and a mean aneurysm
diameter of 62 mm (range, 42-110 mm). The mean intraoperative contrast use was 67 mL (range, 45-160 mL), and after
surgery these patients received a mean of 3 surveillance computed tomographic scans (range, 1-7). Nineteen cases (13.6%)
required deliberate accessory renal artery coverage. CrCl did not change significantly after surgery; the mean change in CrCl
at the end of follow-up was a 2.5% decrease. There was no difference in the reduction in CrCl between endograft types. Only
14.3% of patients experienced a greater than 20% decrease in CrCl. Multiple regression analysis failed to show a relationship
between change in renal function and age, sex, aneurysm diameter, infrarenal neck dimensions, endograft type, coverage of
accessory renal arteries, intraoperative contrast volume, preoperative CrCl, and postoperative computed tomographic scans.
Length of follow-up was an independent predictor (P  .04).
Conclusions: Transrenal endograft fixation results in little deterioration in renal function during intermediate follow-up.
The few patients who do experience a decline in renal function do so independently of any features related to the initial
endovascular repair, and there is no difference in renal deterioration between endografts with nitinol and stainless steel
transrenal bare metal stents. ( J Vasc Surg 2006;44:938-42.)Although the endovascular approach to infrarenal an-
eurysm repair has been widely adopted and accepted, in-
creasingly challenging aortic anatomy has been encoun-
tered. Consequently, the use of this technique in the
presence of unfavorable aortic neck features, including
calcification, tortuosity, lining with thrombus, larger diam-
eters, and shorter lengths, has raised concerns regarding
the long-term durability of this procedure. In response,
endograft design evolved to include bare metal transrenal
fixation. Many centers have subsequently reported favor-
able early and mid-term outcomes with several transrenally
fixated endografts.1-3
Coinciding with these reports of improved durability
were concerns as to the potentially deleterious effects of
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938metal struts crossing the renal artery ostia. As a result,
several authors reviewed their experience and, reassuringly,
reported no difference in renal dysfunction between infra-
renal and transrenally placed endografts.4-7 However, these
studies grouped transrenally placed endografts together
and failed to explore any differences in postoperative renal
dysfunction between different devices. Furthermore, some
investigators have observed different biological responses
to various metals when the renal ostia are crossed. Specifi-
cally, in an animal model, nitinol stents exhibited greater
collagen matrix deposition than those composed of stain-
less steel and had a greater effect on renal artery flow when
placed across the ostia.8
This animal data and the lack of direct comparisons of
the effect of different transrenally fixated endografts on
renal function prompted this study. The study’s purpose
was to determine whether there is any difference in postop-
erative renal function after the transrenal placement of a
nitinol and a stainless steel endograft.
METHODS
Our vascular surgery database was retrospectively
reviewed to identify all patients who underwent elective
endovascular abdominal aortic aneurysm repair at our
university-affiliated medical center between August 2003
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aneurysm anatomy, and procedural details was reviewed.
Aneurysm and aortic measurements were determined by
using a General Electric Advantage (General Electric,
Waukesha, Wis) workstation with semiautomatic vessel-
analysis software. Data were entered into the database at
the time of measurement and reviewed retrospectively.
Preoperative and the most recent postoperative creatinine
(Cr) levels, as well as age and preoperative weight, were
applied to the Cockcroft-Gault formula,
CrCl (140 age) weight ⁄ (Cr 72),
to calculate creatinine clearance (CrCl).9 Although weight
can change over time, the initial weight was used for all
calculations because any changes were predicted to be
minor. The main outcome measure was the percentage
change in CrCl and a greater than 20% decline in CrCl, as
has been used previously as a measure of renal function
deterioration.7
One of two commercially available endografts, Talent
(Medtronic, Santa Rosa, Calif) and Zenith (Cook, Bloom-
ington, Ind), providing transrenal bare metal fixation was
used in this series at the discretion of the operating surgeon.
The stainless-steel uncovered portion of the Zenith en-
dograft is 26 mm long with 10 to 12 struts (depending on
graft diameter) with 3-mm barbs, whereas that of the
Talent endograft is 15 mm high with 5 struts, each of 0.5
mm diameter, and is comprised of nitinol. Transrenal fixa-
tion of the bare metal portion of the endografts was con-
firmed in all patients with completion angiograms and
postoperative computed tomographic (CT) scans. Both
endograft groups were compared with respect to patient
demographics, aneurysm anatomy, procedural details, and
postoperative renal function. Group means and propor-
tions were compared by using unpaired t tests and Fisher
exact tests with a P  .05 level of statistical significance.
Multiple regression analysis was performed to analyze
the contribution of various factors to a deterioration in
renal function, defined as a greater than 20% decrease in
CrCl. Factors included in the multiple regression modeling
were age, sex, presence of hypertension, medications, an-
eurysm diameter, infrarenal neck dimensions, endograft
type, coverage of accessory renal arteries, intraoperative
contrast volume, number of postoperative CTs, and length
of follow-up. Statistical analysis was performed with InStat
version 3.06 (GraphPad Software, San Diego, Calif) and a
P  .05 level of statistical significance. This study received
approval from the University of Western Ontario Research
Ethics Board for Health Sciences Research Involving Hu-
man Subjects.
RESULTS
During this 20-month period, 140 patients underwent
elective endovascular repair of an infrarenal aortic aneurysm
at our center. No patient was excluded from analysis. One
of two commercially available endografts was used, each
with bare metal transrenal fixation. The Talent device con-
tains a nitinol-based stent framework, whereas the Zenithdevice uses stainless steel. A Talent endograft was used in
59 patients, and 81 patients received the Zenith graft.
There was no statistically significant difference between the
endograft groups with respect to age (74.3 7.6 years and
75.4  8.0 years; P  .44), sex distribution (89.8% and
82.7% male; P  .33), or preoperative aneurysm diameter
(61.3  6.7 mm and 63.2  10.7 mm; P  .23), as
summarized in Table I.
Aneurysms repaired with the Talent graft had signifi-
cantly larger-diameter aortic necks (24.8  3.4 mm and
23.7  2.8 mm; P  .04); this resulted in proximal en-
dograft diameters tending to be larger than in the Zenith
group (29.9  3.1 mm and 29.0  2.3 mm; P  .06),
although this did not reach statistical significance (Table I).
The length of the infrarenal aortic neck did not differ
between endograft groups (27.3  11.5 mm and 30.0 
13.8 mm; P  .23). During surgery, equivalent propor-
tions of patients received deliberate accessory renal artery
coverage (10.2% and 16.0%; P  .45), and the intraopera-
tive contrast load did not differ between endograft groups
(65.1  15.1 mL and 71.1  20.8 mL; P  .06). There
were no cases of inadvertent main renal artery coverage.
Additionally, the mean length of follow-up after surgery
(5.4 4.2 months and 5.4 4.5 months; P .9) and the
number of postoperative CT scans (3.2  1.5 and 2.8 
1.3; P  .09) were similar. The mean length of follow-up
for the entire cohort was 5.4 months (range, 1-22 months;
median, 3 months).
Table II and the Fig summarize the data pertaining to
renal function. Preoperative (74.8 30.8 and 65.1 26.9;
P .05) and postoperative (73.8 31.9 and 66.0 31.4;
P  .15) CrCl (mL/min) did not differ between groups,
although the preoperative values approached significance.
Additionally, there was no significant change in CrCl when
comparing postoperative and preoperative values for each
endograft (Talent, P  .86; Zenith, P  .83) and when
comparing the mean decrease in CrCl between endografts
Table I. Comparison between the two endograft groups
Variable Talent Zenith P value
n 59 81 —
Age (y) 74.3  7.6 75.4  8.0 .44
% Male 89.8 82.7 .33
AAA diameter (mm) 61.3  6.7 63.2  10.7 .23
AAA neck diameter (mm) 24.8  3.4 23.7  2.8 .04
AAA neck length (mm) 27.3  11.5 30.0  13.8 .23
Proximal graft diameter
(mm) 29.9  3.1 29.0  2.3 .06
Accessory renal artery
coverage (%) 10.2 16.0 .45
Intraoperative contrast
volume (mL) 65.1  15.1 71.1  20.8 .06
Postoperative CTs 3.2  1.5 2.8  1.3 .09
Length of follow-up from
date of surgery (mo) 5.4  4.2 5.4  4.5 .9
AAA, Abdominal aortic aneurysm; CT, computed tomography.
Data are presented as mean  SE unless otherwise noted.(3.3%  2.3% and 2.0%  1.1%; P  .7). Similar propor-
JOURNAL OF VASCULAR SURGERY
November 2006940 Forbes et altions of patients with each endograft experienced a greater
than 20% decrease in CrCl (13.5% and 14.8%; P  .9)
during follow-up. The extent of deterioration in these
particular patients was similar between endografts. No pa-
tient required postoperative dialysis.
A multiple regression analysis was performed to evalu-
ate the role of individual factors and a greater than 20%
decline in CrCl. As shown in Table III, the sole predictive
factor with respect to a postoperative decline in renal func-
tion was length of follow-up (P  .04).
DISCUSSION
The use of transrenally fixated endografts offers several
potential advantages compared with infrarenally placed grafts.
The transrenal bare metal component effectively lengthens
the proximal attachment site, thus resulting in fewer type I
endoleaks and possibly a more durable repair.1-3,10 How-
ever, there were concerns regarding the renal effects of
metal stents placed across the renal artery ostia which have
been explored by a number of investigators using several
Table II. Comparison of renal function between the two
endograft groups
Variable Talent Zenith P value
Preoperative CrCl
(mL/min) 74.8  30.8 65.1  26.9 .05
Postoperative CrCl
(mL/min) 73.8  31.9 66.0  31.4 .15
Decrease in CrCl (%) 3.3  2.3 2.0  1.1 .7
20% decrease in
CrCl (%) 13.5 14.8 .9
CrCl, Creatinine clearance.
Data are presented as mean  SD unless otherwise noted.
Fig. Box plot displaying the change in creatinine clearance (CrCl)
after endovascular aneurysm repair. Each box extends from the
25th to 75th percentile, and the central line represents the 50th
percentile. Lines extending from the box are the most extreme
observations not more than 1.5 times the height of the box beyond
either quartile. Black dots represent outliers.models.With the in vitro pulsatile circulation model, the Co-
logne group showed that renal artery flow was not acutely
compromised by the transrenal placement of bare metal
stents and that any progressive decline in renal function
would be attributed to neointimal hyperplasia, rather than
an acute disruption in flow dynamics.11 Further animal
models echoed these findings with neointimal hyperplasia
on bare metal struts 1 month after transrenal fixation in a
porcine model, resulting in renal artery stenoses and renal
dysfunction as measured by increased serum Cr levels.12
Equally concerning was the apparent increase in renal in-
farctions after transrenal fixation. Using a sheep model,
German investigators observed an increased incidence of
renal infarctions after transrenal fixation compared with
infrarenally placed grafts (58.3% vs 25%; P  .04).13 Al-
though not limited to endografts with transrenal fixation,
renal infarcts were certainly more common with these
grafts.
Differences between types of metal and the neointimal
response have been investigated by using animal models
and, at least in part, were the basis of this study. Using a
porcine model, the Sheffield group investigated the differ-
ences between transrenally placed stainless steel and nitinol
stents.8 They observed that after 6 to 15 weeks, all animals
displayed an organized cellular matrix with endothelial cells
covering the stent struts, with nitinol stents inducing a
more aggressive and disorganized acellular matrix and of-
ten causing partial renal ostial occlusion. The investigators
postulated that this might be attributed to the chemical
properties of nitinol or its unpolished condition that could
cause increased reactivity and thrombogenicity.
As a result of this concern regarding renal deterioration
after endovascular aneurysm repair, postrepair renal func-
tion has been reviewed and compared between transrenally
and infrarenally placed endografts and open repair groups.
Table III. Multiple regression for a greater than 20%
decrease in CrCl
Variable P value Coefficient
Lower
95% CI
Upper
95% CI
Age .89 0.0006 0.008 0.009
Sex .82 0.073 0.249 0.102
Hypertension .64 0.036 0.190 0.118
Medications .47 0.057 0.099 0.213
Preoperative CrCl .85 0.0002 0.0009 0.002
AAA diameter .61 0.002 0.009 0.102
Neck diameter .11 0.027 0.006 0.060
Neck length .07 0.004 0.002 0.009
Endograft .83 0.013 0.116 0.143
Endograft diameter .32 0.019 0.055 0.018
Accessory renal artery
coverage .22 0.111 0.111 0.067
Contrast .60 0.0009 0.002 0.004
Postoperative CTs .77 0.007 0.023 0.038
Length of follow-up .04 0.014 0.007 0.030
CrCl, Creatinine clearance; CI, confidence interval; AAA, abdominal aortic
aneurysm; CT, computed tomography.The Zenith investigators found no difference in serum Cr
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endovascular aneurysm repair with the Zenith endograft
and transrenal fixation.14 They did observe a postoperative
decline in CrCl in both groups which has been observed in
other reports of endovascular aneurysm repair.4,5,15,16
This, however, did not seem to be any different from the
normal elderly population, who experience a yearly 2%
decline in CrCl after 75 years of age.17 Whether this decline
in renal function after transrenal fixation plateaus after
several years, as suggested by some authors,14 or continues
will require longer follow-up.
These findings are consistent with those of other
groups who have found transrenal fixation to be safe2,10,18
and to not cause greater renal dysfunction compared with
infrarenally fixated endografts.4-7,15,16,19 A gradual decline
in renal function is a consistent postoperative finding in
these studies, although this progressive renal insufficiency
after endovascular repair is similar with transrenal and in-
frarenal fixation. It also seems to be independent of pre-
existing renal artery stenoses1,16 and accessory renal artery
coverage.16,20 Several of these reports described the use of
different transrenally fixated endografts but failed to com-
pare these endografts in regard to renal function deteriora-
tion.5,7,18
This study used CrCl as a measure of renal function.
Although the Cockcroft-Gault formula may overestimate
glomerular filtration rate by as much as 16%,21 it is viewed
as more accurate and relevant than serum Cr alone in
determining renal function. As with previous studies,7,15 a
20% reduction in CrCl was determined to be a clinically
significant decline in renal function. After approximately
6 months of follow-up, the Talent and Zenith groups
showed similar mild effects on CrCl. There was no differ-
ence in several factors that might contribute to renal dys-
function, including intraoperative contrast volume, acces-
sory renal artery coverage, and preoperative serumCr. Both
endograft groups had similar numbers of patients who
experienced a greater than 20% decline in CrCl, and length
of follow-up was the only significant independent predictor
after multiple regression analysis. One possible factor that
was not examined was the effect of pre-existing renal artery
stenoses. This has been reviewed by Marin et al,1 who
found that the preoperative presence of renal artery steno-
ses did not result in greater renal dysfunction after transre-
nal endograft placement.
Of course, the metal composition of the bare stents is
not the only difference between the Talent and Zenith
endografts. Along with being composed of stainless steel,
the Zenith bare metal component has more struts than its
Talent counterpart and, as a result, is more likely to cross
renal artery orifices. The placement of stents across the ostia
is unpredictable with endograft deployment but could re-
sult in different flow patterns across the ostia, depending on
this orientation. This effect on flow patterns has been
investigated by an Australian group, who found that differ-
ent configurations of stents across an arterial orifice had a
minimal effect on blood flow into arteries greater than 3
mm in diameter, as long as there was no buildup on thewire.22 Potentially, the effects of the possibly greater
thrombogenicity of the nitinol-based stent could be bal-
anced by the fewer stent bars in the Talent endograft
protecting against greater renal dysfunction. In the mid
term, however, there is no difference in renal dysfunction
observed with the different endografts; whether this per-
sists in the longer term is outside the realm of this study and
will require longer follow-up.
Several shortcomings of this study have already been
mentioned and include the retrospective nonrandomized
design. Data pertaining to kidney size, aortic thrombus or
calcification, renal artery stenoses, and renal infarcts were
not available. Renal artery stenoses have not been found to
contribute significantly to renal dysfunction after endovas-
cular repair,1 and although renal infarcts are more common
after transrenal fixation compared with infrarenal fixation,
they seem relatively benign with respect to postoperative
renal dysfunction.19 This study describes the short- to
mid-term follow-up of patients, and whether these findings
persist will require additional follow-up. Whether this sim-
ilarity between these transrenally fixated endografts, with
respect to renal function, is maintained has yet to be deter-
mined. Additionally, the possibility that there is a small
difference that would have been statistically significant with
greater numbers of patients does exist, although the num-
ber of patients described in this report is similar to those in
others.
Regardless, this study confirms that transrenal fixation
of endografts causes little deterioration in renal function
and that, despite concerns of differing properties, nitinol
and stainless steel–composed bare metal stents behave clin-
ically similarly in regard to renal function.
AUTHOR CONTRIBUTIONS
Conception and design: TLF, GEJH, DKL, GD, KAH
Analysis and interpretation: TLF, GEJH, DKL, GD, KAH
Data collection: TLF
Writing the article: TLF
Critical revision of the article: TLF, GEJH, DKL, GD,
KAH
Final approval of the article: TLF, GEJH, DKL, GD, KAH
Statistical analysis: TLF
Overall responsibility: TLF
REFERENCES
1. Marin ML, Parsons RE, Hollier LH, Mitty HA, Ahn J, Parsons RE, et al.
Impact of transrenal aortic endograft placement on endovascular graft
repair of abdominal aortic aneurysms. J Vasc Surg 1998;28:638-46.
2. Lobato AC, Quick RC, Vaughn PL, Rodriguez-Lopez J, Douglas M,
Diethrich EB. Transrenal fixation of aortic endografts: intermediate
follow-up of a single-center experience. J Endovasc Ther 2000;7:273-8.
3. Abraham CZ, Chuter TAM, Reilly LM, Okuhn SP, Perthan LK, Kerlan
RB, et al. Abdominal aortic aneurysm repair with the Zenith stent graft:
short to midterm results. J Vasc Surg 2002;36:217-25.
4. Parmer SS, Carpenter JP. Endovascular aneurysm repair with suprarenal vs
infrarenal fixation: a study of renal effects. J Vasc Surg 2006;43:19-25.
5. Cayne NS, Rhee SJ, Veith FJ, Lipsitz EV, Ohki T, Gargiulo NJ, et al.
Does transrenal fixation of aortic endografts impair renal function?
J Vasc Surg 2003;38:639-44.
JOURNAL OF VASCULAR SURGERY
November 2006942 Forbes et al6. Lau LL, Hakaim AG, Oldenburg WA, Neuhauser B, McKinney JM,
Pax-Fumagalli R. Effect of suprarenal versus infrarenal aortic endograft
fixation on renal function and renal artery patency: a comparative study
with intermediate follow-up. J Vasc Surg 2003;37:1162-8.
7. Alsac JM, Zarins CK, Heikkinen MA, Karkowski J, Arko FR, Des-
granges P, et al. The impact of aortic endografts on renal function.
J Vasc Surg 2005;41:926-30.
8. Birch PC, Start RD, Whitbread T, Palmer I, Gaines PA, Beard JD. The
effects of crossing porcine renal artery ostia with various endovascular
stents. Eur J Vasc Endovasc Surg 1999;17:185-90.
9. Cockcroft MH, Gault DW. Prediction of creatinine clearance from
serum creatinine. Nephron 1976;16:31-41.
10. Bove RG, Long GW, Zelenock GB, Bendick PJ, Khoury MD, Burr
MO, et al. Transrenal fixation of aortic stent-grafts for the treatment of
infrarenal aortic aneurysmal disease. J Vasc Surg 2000;32:697-703.
11. Gawenda M, Winter S, Jaschke G, Brunkwall J. Stent jail of the renal
arteries in stent graft exclusion of AAA. An in vitro study of 3 different
stent types. J Cardiovasc Surg (Torino) 2002;43:857-63.
12. Desgranges P, Hutin E, Kedzia C, Allaire E, Becquemin JP. Aortic
stents covering the renal arteries ostia: an animal study. J Vasc Interv
Radiol 1997;8:77-82.
13. Kramer SC, Gorich J, Bachmann R, Fuge D, Kuhnt B, Scharrer-Pamler
R. Incidence of renal infarctions after transrenal stent placement in an
animal model. J Endovasc Ther 2005;12:312-7.
14. Greenberg RK, Chuter TA, Lawrence-Brown M, Haulon S, Nolte L.
The Zenith Investigators. Analysis of renal function after aneurysm
repair with a device using suprarenal fixation (Zenith AAAEndovascular
Graft) in contrast to open surgical repair. J Vasc Surg 2004;39:1219-28.
15. Alric P, Hinchliffe RJ, Picot MC, Braithwaite BD, MacSweeney ST,
Wenham PW, et al. Long-term renal function following endovascularaneurysm repair with infrarenal and suprarenal aortic stent-grafts.
J Endovasc Ther 2003;10:397-405.
16. Surowice SM, Davies MG, Fegley AJ, Tanski WJ, Pamoukian VN,
Sternbach Y, et al. Relationship of proximal fixation to postoperative
renal dysfunction in patients with normal serum creatinine concentra-
tion. J Vasc Surg 2004;39:804-10.
17. Tiao JY, Semmens JB, Masarci JR, Lawrence-BrownMM. The effect of
age on serum creatinine level in an aging population: relevance to
vascular surgery. Cardiovasc Surg 2002;10:445-51.
18. Burks JA, Faries PL, Gravereaux EC, Hollier LH, Marin ML. Endovas-
cular repair of abdominal aortic aneurysms: stent-graft fixation across
the visceral arteries. J Vasc Surg 2002;35:109-13.
19. Bockler D, Krauss M, Mansmann U, Halawa M, Lange R, Probst T,
et al. Incidence of renal infarctions after endovascular AAA repair:
relationship to infrarenal versus suprarenal fixation. J Endovasc Ther
2003;10:1054-60.
20. Karmacharya J, Parmer SS, Antezana JN, Fairman RM, Woo EY,
Velazquez OC, et al. Outcomes of accessory renal artery occlusion
during endovascular aneurysm repair. J Vasc Surg 2006;43:8-13.
21. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more
accurate method to estimate glomerular filtration rate from serum
creatinine: a new prediction equation. Modification of Diet in Renal
Disease Study Group. Ann Intern Med 1999;130:461-70.
22. Liffman K, Lawrence-Brown MM, Semmens JB, Sutalo ID, Bui A,
White F, et al. Suprarenal fixation: effect on blood flow of an endolu-
minal stent wire across an arterial orifice. J Endovasc Ther 2003;10:
260-74.Submitted Jun 6, 2006; accepted Jul 19, 2006.
